Lefamulin最初由Nabriva开发,2018年3月仑胜医药获得在大中华区,包括中国大陆、香港、澳门、台湾开...查看全文
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 美东时间 2015-11-11 09:00 Before Open:NABRIVA THERPTC Earning Release . Wall St EPS Est ($):-1.83. 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2015-11-10 AccNo: 0001104659-15-077720 Size: 2 MB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 美东时间 2015-11-11 08:30 Q3 2015 Nabriva Therapeutics AG Earnings Call 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 美东时间 2015-11-02 Nabriva Therapeutics AG at EBD BIO Europe- Fall 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2015-09-29 AccNo: 0001193125-15-331175 Size: 142 KB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2015-09-25 AccNo: 0001193125-15-329003 Size: 43 KB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2015-10-05 AccNo: 0001104659-15-069102 Size: 95 KB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ SC 13D - General statement of acquisition of beneficial ownership Filed: 2015-10-02 AccNo: 0000947871-15-000713 Size: 169 KB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses Filed: 2015-09-18 AccNo: 0001193125-15-322685 Size: 64 KB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ F-6 POS - Post-effective amendments for immediately effective filing Filed: 2015-09-21 AccNo: 0001019155-15-000315 Size: 286 KB 网页链接